Literature DB >> 31376211

Body mass index, abdominal fatness, weight gain and the risk of urinary incontinence: a systematic review and dose-response meta-analysis of prospective studies.

D Aune1,2,3, Y Mahamat-Saleh4,5, T Norat1, E Riboli1.   

Abstract

BACKGROUND: Adiposity has been associated with elevated risk of urinary incontinence in epidemiological studies; however, the strength of the association has differed between studies.
OBJECTIVES: To conduct a systematic literature review and dose-response meta-analysis of prospective studies on adiposity and risk of urinary incontinence. SEARCH STRATEGY: We searched PubMed and Embase databases up to 19 July 2017. SELECTION CRITERIA: Prospective cohort studies were included. DATA COLLECTION AND ANALYSIS: Data were extracted by one reviewer and checked for accuracy by a second reviewer. Summary relative risks (RRs) and 95% confidence intervals (CIs) were calculated using random effects models. MAIN
RESULTS: Twenty-four prospective studies were included. The summary RR per 5 kg/m2 increment in body mass index (BMI) was 1.20 (95% CI 1.16-1.25, I2  = 62%, n = 11) for population-based studies and 1.19 (95% CI 1.08-1.30, I2  = 87.1%, n = 8) for pregnancy-based studies, 1.18 (95% CI 1.14-1.22, I2  = 0%, n = 2) per 10 cm increase in waist circumference and 1.34 (95% CI 1.11-1.62, I2  = 90%, n = 2) per 10 kg of weight gain. Although the test for nonlinearity was significant for BMI, P = 0.04, the association was approximately linear. For subtypes of urinary incontinence the summary RR per 5 BMI units was 1.45 (95% CI 1.25-1.68, I2  = 85%, n = 3) for frequent incontinence, 1.52 (95% CI 1.37-1.68, I2  = 34%, n = 4) for severe incontinence, 1.33 (95% CI 1.26-1.41, I2  = 0%, n = 8) for stress incontinence, 1.26 (95% CI 1.14-1.40, I2  = 70%, n = 7) for urge incontinence, and 1.52 (95% CI 1.36-1.69, I2  = 0%, n = 3) for mixed incontinence.
CONCLUSION: These results suggest excess weight may increase risk of urinary incontinence. TWEETABLE ABSTRACT: Overweight and obesity increase the risk of urinary incontinence.
© 2019 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  zzm321990Body mass indexzzm321990; meta-analysis; obesity; overweight; prospective studies; urinary incontinence; waist circumference

Mesh:

Year:  2019        PMID: 31376211     DOI: 10.1111/1471-0528.15897

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  5 in total

Review 1.  Prevalence of urinary incontinence in female CrossFit athletes: a systematic review with meta-analysis.

Authors:  Eladio Dominguez-Antuña; José Carlos Diz; David Suárez-Iglesias; Carlos Ayán
Journal:  Int Urogynecol J       Date:  2022-05-30       Impact factor: 1.932

2.  Remission and Transition of Female Urinary Incontinence and Its Subtypes and the Impact of Body Mass Index on This Progression: A Nationwide Population-Based 4-Year Longitudinal Study in China.

Authors:  Haiyu Pang; Tao Xu; Zhaoai Li; Jian Gong; Qing Liu; Yuling Wang; Juntao Wang; Zhijun Xia; Lan Zhu
Journal:  J Urol       Date:  2022-04-15       Impact factor: 7.600

3.  Maternal risk factors of urinary incontinence during pregnancy and postpartum: A prospective cohort study.

Authors:  Anna Rajavuori; Jussi P Repo; Arja Häkkinen; Pirkko Palonen; Juhani Multanen; Pauliina Aukee
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2021-11-08

4.  Urethral configuration and mobility during urine leaking described using real-time transperineal ultrasonography.

Authors:  Baihua Zhao; Lieming Wen; Dan Liu; Shanya Huang
Journal:  Ultrasonography       Date:  2021-06-15

5.  Efficacy of mirabegron, a β3 -adrenoreceptor agonist, in Japanese women with overactive bladder and either urgency urinary incontinence or mixed urinary incontinence: Post-hoc analysis of pooled data from two randomized, placebo-controlled, double-blind studies.

Authors:  Satoru Takahashi; Yuji Mishima; Kentaro Kuroishi; Masashi Ukai
Journal:  Int J Urol       Date:  2021-10-04       Impact factor: 2.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.